Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | DRD4 | P21917 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4578208 | 0.90 | KDM4E (0.85) | KDM4EPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL6754439 | 0.89 | USP2 (0.81) | KDM4EPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL4866196 | 0.87 | TP53 (0.73) | KDM4EMEN1KMT2AL3MBTL1MAPK1 | |
| SCHEMBL20444278 | 0.86 | KMT2A (0.76) | KDM4EPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL7297907 | 0.86 | KCNH2 (0.71) | KDM4EKMT2AMAPK1GLAUSP2 | |
| SCHEMBL12402885 | 0.86 | ATM (0.61) | KDM4EPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL5754770 | 0.86 | TSHR (0.67) | KDM4EPOLBMEN1KMT2AGLA | |
| SCHEMBL12402888 | 0.86 | ATM (0.61) | KDM4EPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL31094186 | 0.86 | KDM4E (0.56) | KDM4EPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL24322808 | 0.85 | L3MBTL1 (0.77) | KDM4EPOLBMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7407960-B2 | Substituted heterocyclic compounds | CV THERAPEUTICS, INC. (US) | 2008-08-05 | — | — | US | disclosed |
| EP-1806346-A1 | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | CV THERAPEUTICS, INC. (US) | 2007-07-11 | — | — | EP | disclosed |
| US-20070004751-A1 | Substituted heterocyclic compounds | ELZEIN ELFATIH | 2007-01-04 | — | — | US | disclosed |
| US-7125876-B2 | Substituted heterocyclic compounds | CV THERAPEUTICS, INC. (US) | 2006-10-24 | — | — | US | disclosed |
| US-7056924-B2 | Substituted heterocyclic compounds | CV THERAPEUTICS, INC. (US) | 2006-06-06 | — | — | US | disclosed |
| US-7001909-B2 | Substituted heterocyclic compounds | CV THERAPEUTICS, INC. (US) | 2006-02-21 | — | — | US | disclosed |
| US-20050260518-A1 | Heat sensitive recording material and microcapsule | FUJI PHOTO FILM CO., LTD. | 2005-11-24 | — | — | US | disclosed |
| EP-1583760-A2 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | CV Therapeutics Inc. (US) | 2005-10-12 | — | — | EP | disclosed |
| EP-1567525-A2 | SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS | CV THERAPEUTICS, INC. (US) | 2005-08-31 | — | — | EP | disclosed |
| US-6930111-B2 | Substituted heterocyclic compounds | CV THERAPEUTICS, INC. (US) | 2005-08-16 | — | — | US | disclosed |
| US-20010019806-A1 | Azomethine dye precursor, image-forming material, and image-forming method | FUJIFILM CORPORATION (JP) | 2001-09-06 | — | — | US | disclosed |
| US-5935757-A | HIGH COLOR DEVELOPING SENSITIVITY AND EXCELLENT STORABILITY. USING AN ESTER- OR AMIDE CONTAINING SULFOAMIDOBENZENE IN A LAYER CONTAINING A DIAZONIUM SALT AND A REACTIVE COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1999-08-10 | — | — | US | disclosed |
| US-5925489-A | CONTAINING DIAZONIUM SALT AND PYRROLOPYRIMIDINE COUPLER WHICH REACT WHEN HEATED TO DEVELOP VIOLET TO CYAN COLORS, IMAGE QUALITY AND STABILITY, SHELF LIFE | FUJI PHOTO FILM CO., LTD. (JP) | 1999-07-20 | — | — | US | disclosed |
| US-5866293-A | CONTAINING DIAZO COMPOUND AND PYRAZOLONE COUPLER; STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1999-02-02 | — | — | US | disclosed |
| EP-0327318-B1 | Heat-sensitive recording materials | FUJI PHOTO FILM CO LTD (JP) | 1995-07-19 | — | — | EP | disclosed |
| EP-0337734-B1 | Heat-developable diazo copying material | FUJI PHOTO FILM CO LTD (JP) | 1995-03-08 | — | — | EP | disclosed |
| EP-0327318-A2 | Heat-sensitive recording materials | FUJI PHOTO FILM CO., LTD. (JP) | 1989-08-09 | — | — | EP | disclosed |
| US-4567264-A | ADRENERGIC BLOCKING AGENTS | SYNTEX (U.S.A.) INC. (US) | 1986-01-28 | — | — | US | disclosed |
| EP-0126449-A1 | Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry | SYNTEX (U.S.A.) INC. (US) | 1984-11-28 | — | — | EP | disclosed |
| US-4269838-A | ADRENERGIC BLOCKING AGENTS; ANTIARRHYTHMIA AND HYPOTENSIVE AGENTS | NIPPON SHINYAKU CO. LTD. (JP) | 1981-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004751-A1 | Substituted heterocyclic compounds | KCNH1, SDHA, COQ8A | KDM4E 2949/4885POLB 2485/4885MEN1 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.